Equities research analysts at StockNews.com assumed coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Price Performance
NASDAQ:CHEK opened at $1.11 on Friday. Check-Cap has a 1 year low of $1.10 and a 1 year high of $3.94. The stock’s fifty day moving average price is $1.58 and its two-hundred day moving average price is $1.93. The company has a market cap of $6.49 million, a P/E ratio of -0.37 and a beta of 0.36.
About Check-Cap
Recommended Stories
- Five stocks we like better than Check-Cap
- How to Capture the Benefits of Dividend Increases
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- 5 Top Rated Dividend Stocks to Consider
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is a Special Dividend?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.